Skin cancer breakthrough delivers second act for Moderna's mRNA vaccines | The National
--------------------------------------------------------------------
Source: The National (UAE)
Published: 2026-08-20 13:51 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Law & Courts, World News, Crime & Justice, Technology
--------------------------------------------------------------------
Snippet:
A personalised vaccine developed by Moderna and Merck reduced the recurrence of melanoma in a large, late-stage trial, raising expectations for treating the deadliest form of skin cancer and showing the promise of the embattled mRNA technology.
--------------------------------------------------------------------